Thromb Haemost 2001; 85(05): 929-931
DOI: 10.1055/s-0037-1615770
Scientific and Standardization Committee Communication
Schattauer GmbH

A Standard Nomenclature for von Willebrand Factor Gene Mutations and Polymorphisms

On behalf of the ISTH SSC Subcommittee on von Willebrand Factor
A. C. Goodeve
1   Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, UK
,
J. C. J. Eikenboom
2   Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands
,
D. Ginsburg
3   Howard Hughes Medical Institute, University of Michigan, Ann Arbor MI, USA
,
L. Hilbert
4   Laboratoire Français du Fractionnement et des Biotechnologies, Lille, France
,
C. Mazurier
4   Laboratoire Français du Fractionnement et des Biotechnologies, Lille, France
,
I. R. Peake
1   Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, UK
,
J. E. Sadler
5   Washington University School of Medicine, St. Louis, MO, USA
,
F. Rodeghiero
6   Hematology Department, S. Bortolo Hospital, Vicenza, Italy
› Author Affiliations
Further Information

Publication History





Publication Date:
11 December 2017 (online)

Summary

Examination of the entire von Willebrand factor (VWF) gene for mutations, particularly in types 1 and 3 von Willebrand disease (VWD) is becoming more widely practised. The sequence of the entire VWF gene will soon be compiled as a single sequence. For these reasons, a clearly defined nomenclature to use for numbering the VWF nucleotide and amino acid sequence is required.

The following recommendations are made for VWF numbering. VWF cDNA nucleotide sequence should be numbered from the A of the initiator ATG as the +1 position. Genomic DNA should be prefixed with a “g” and also numbered from this position. Amino acid (aa) numbering should be from the initiator methionine as the +1 position with sequential numbering of aa throughout VWF. To avoid confusion with previously used numbering schemes for mature VWF, which started from serine 764 of pre-pro VWF, the use of the single letter amino acid code is recommended.

 
  • References

  • 1 Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
  • 2 Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von Willebrandfactor. J Biol Chem 1989; 264: 19514-27.
  • 3 Peake I, Tuddenham E. A standard nomenclature for factor-VIII and factor-IX gene mutations and associated amino-acid alterations. Thromb Haemost 1994; 72: 475-6.